Clinical trials recruiting for Alzheimer's Disease (AD)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Atomoxetine | 1 |
| Metformin 1000 mg Oral Tablet | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
- Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
- Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study
- Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
Related conditions
Trials recruiting for Alzheimer's Disease (AD) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Alzheimer's Disease (AD) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.